Today, ‘disability justice is reproductive justice’ — but that hasn’t always been the case
By Sara Luterman,
The 19th News
| 05. 23. 2024
Historically, the disability and reproductive rights movements have operated separately, “just ignoring each other,” as one advocate put it, as they pursued aims that at times felt contradictory: While one movement fought for full abortion access, the other sought for people to stop ending pregnancies where disabilities were detected. A new House resolution announced Thursday by Rep. Ayanna Pressley highlights shifts in the movements’ relationship accelerated by the end of federal abortion rights and growing acknowledgement of common ground: bodily autonomy and self-determination.
Advocates for reproductive and disability rights and justice were set to gather with Pressley, a Massachusetts Democrat, outside the U.S. Capitol to announce the Disability Reproductive Equity Act. The resolution would establish an annual Disability Reproductive Equity Day in May to highlight the unmet reproductive health care needs of the disability community.
“Disability justice is reproductive justice, and we cannot have one without the other. I am so proud to work with advocates from all walks of life and put forward this necessary, intersectional legislation,” Pressley said in an exclusive comment shared with The 19th.
A matching...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...